Miller Edward

Company

Date

Role

Action

Shares

Amount

Of holding

KLRS Kalaris Therapeutics, Inc.

21 Feb 2025

General Counsel

Sold at will

106

$1.07K

1.6%

KLRS Kalaris Therapeutics, Inc.

23 Jan 2025

General Counsel

Sold at will

52

$494.03

0.8%

KLRS Kalaris Therapeutics, Inc.

10 Jan 2025

General Counsel

Sold at will

409

$180.00

0.3%

KLRS Kalaris Therapeutics, Inc.

19 Nov 2024

General Counsel

Sold at will

432

$236.95

0.2%

KLRS Kalaris Therapeutics, Inc.

5 Nov 2024

General Counsel

Sold at will

2,272

$1.97K

1.1%

KLRS Kalaris Therapeutics, Inc.

22 Oct 2024

General Counsel

Sold at will

766

$588.13

0.4%

KLRS Kalaris Therapeutics, Inc.

21 Oct 2024

General Counsel

Sold at will

635

$494.67

0.3%

KLRS Kalaris Therapeutics, Inc.

3 Oct 2024

General Counsel

Sold at will

377

$307.18

0.2%

KLRS Kalaris Therapeutics, Inc.

19 Aug 2024

General Counsel

Sold at will

422

$320.51

0.2%

KLRS Kalaris Therapeutics, Inc.

5 Aug 2024

General Counsel

Sold at will

2,323

$1.71K

1.1%

KLRS Kalaris Therapeutics, Inc.

22 Jul 2024

General Counsel

Sold at will

757

$559.57

0.3%

KLRS Kalaris Therapeutics, Inc.

19 Jul 2024

General Counsel

Sold at will

634

$475.56

0.3%

KLRS Kalaris Therapeutics, Inc.

2 Jul 2024

General Counsel

Sold at will

379

$272.88

0.2%

KLRS Kalaris Therapeutics, Inc.

17 May 2024

General Counsel

Sold at will

420

$314.71

0.2%

KLRS Kalaris Therapeutics, Inc.

3 May 2024

General Counsel

Sold at will

2,311

$1.84K

1.0%

KLRS Kalaris Therapeutics, Inc.

22 Apr 2024

General Counsel

Sold at will

757

$567.75

0.3%

KLRS Kalaris Therapeutics, Inc.

19 Apr 2024

General Counsel

Sold at will

626

$469.88

0.3%

KLRS Kalaris Therapeutics, Inc.

2 Apr 2024

General Counsel

Sold at will

368

$284.10

0.2%

KLRS Kalaris Therapeutics, Inc.

20 Feb 2024

General Counsel

Sold at will

385

$267.65

0.2%

KLRS Kalaris Therapeutics, Inc.

5 Feb 2024

General Counsel

Sold at will

8,869

$5.94K

3.8%

KLRS Kalaris Therapeutics, Inc.

23 Jan 2024

General Counsel

Sold at will

1,302

$873.38

0.6%

KLRS Kalaris Therapeutics, Inc.

4 Jan 2024

General Counsel

Sold at will

424

$270.94

0.2%

KLRS Kalaris Therapeutics, Inc.

20 Jan 2023

General Counsel

Sold, plan not stated

541

$2.78K

0.4%

KLRS Kalaris Therapeutics, Inc.

19 Jan 2023

General Counsel

Sold, plan not stated

2,032

$10.32K

1.3%

KLRS Kalaris Therapeutics, Inc.

14 Nov 2022

General Counsel

Sold, plan not stated

2,358

$21.02K

1.2%

KLRS Kalaris Therapeutics, Inc.

19 Oct 2022

General Counsel

Sold, plan not stated

553

$5.18K

0.2%

KLRS Kalaris Therapeutics, Inc.

1 Mar 2021

General Counsel

Sold, plan not stated

6,000

$232.70K

3.0%